Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Asystole caused by Hydroxycut Hardcore: A case report and literature review.

Literature DB >> 28653348

Asystole caused by Hydroxycut Hardcore: A case report and literature review.

Julie Zaidan¹, Rabih Tabet¹, Boutros Karam¹, Farshid Daneshvar², Mohammed Raza², Soad Bekheit³.

Abstract

Obesity is a rising epidemic worldwide driving people to search for remedy through nonconventional therapies. Hydroxycut products are popular supplements used as weight loss aids. Many reports revealed serious adverse effects related to their ingestion. We report the case of a 37-year-old healthy male patient who presented following an episode of syncope. On telemetry, he manifested recurrent sinus node arrests, including a symptomatic 24 s sinus pause. The patient admitted to taking Hydroxycut Hardcore for 10 days previously. After discontinuation of the drug, his symptoms completely resolved. This is the first case of Hydroxycut-associated syncope secondary to bradyarrhythmia.

Entities: Disease Species

Keywords: Hydroxycut; asystole; dietary supplement; obesity; weight loss

Mesh：

Substances：

Year: 2017 PMID： 28653348 PMCID： PMC6931570 DOI： 10.1111/anec.12479

Source DB: PubMed Journal: Ann Noninvasive Electrocardiol ISSN： 1082-720X Impact factor: 1.468

10 in total

Review 1. Why the United States still needs improved dietary supplement regulation and oversight.

Authors: J D Morrow
Journal: Clin Pharmacol Ther Date: 2008-03 Impact factor: 6.875

2. Hepatoxicity associated with weight-loss supplements: a case for better post-marketing surveillance.

Authors: Ano Lobb
Journal: World J Gastroenterol Date: 2009-04-14 Impact factor: 5.742

3. Proarrhythmic effects of intravenous quinidine, amiodarone, D-sotalol, and almokalant in the anesthetized rabbit model of torsade de pointes.

Authors: András Farkas; István Leprán; Julius Gy Papp
Journal: J Cardiovasc Pharmacol Date: 2002-02 Impact factor: 3.105

Review 4. Asystole caused by Hydroxycut Hardcore: A case report and literature review.

Authors: Julie Zaidan; Rabih Tabet; Boutros Karam; Farshid Daneshvar; Mohammed Raza; Soad Bekheit
Journal: Ann Noninvasive Electrocardiol Date: 2017-06-27 Impact factor: 1.468

5. A case report of atrial fibrillation potentially induced by hydroxycut: a multicomponent dietary weight loss supplement devoid of sympathomimetic amines.

Authors: Abigail Karth; Noa Holoshitz; Clifford J Kavinsky; Richard Trohman; Brian F McBride
Journal: J Pharm Pract Date: 2010-04-08

6. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010.

Authors: Katherine M Flegal; Margaret D Carroll; Brian K Kit; Cynthia L Ogden
Journal: JAMA Date: 2012-01-17 Impact factor: 56.272

Review 7. Hydroxycut hepatotoxicity: a case series and review of liver toxicity from herbal weight loss supplements.

Authors: Lily Dara; Jennifer Hewett; Joseph Kartaik Lim
Journal: World J Gastroenterol Date: 2008-12-07 Impact factor: 5.742

8. (-)-Epigallocatechin-3-O-gallate (EGCG) attenuates the hemodynamics stimulated by caffeine through decrease of catecholamines release.

Authors: Jin-Yi Han; Yong-Jin Moon; Jong-Hyun Han; Jong-Hoon Kim; Jae-Hoon Woo; Hwan-Soo Yoo; Jin Tae Hong; Hee-Yul Ahn; Jong-Myeon Hong; Ki-Wan Oh
Journal: Arch Pharm Res Date: 2016-07-25 Impact factor: 4.946

9. Ventricular Tachycardia Precipitated by the Use of the Diet Supplement Hydroxycut Gummies.

Authors: Drayton A Hammond; Estela Thano; Kristin A Bohnenberger; Matthew W McAllister; Thomas Wannenburg; Steve Hsu; Bill J Gurley; Robert Kim
Journal: Hosp Pharm Date: 2015-07-31

10. In Silico Evaluation of the Potential Antiarrhythmic Effect of Epigallocatechin-3-Gallate on Cardiac Channelopathies.

Authors: Maroua Boukhabza; Jaouad El Hilaly; Nourdine Attiya; Ahmed El-Haidani; Younes Filali-Zegzouti; Driss Mazouzi; Mohamed-Yassine Amarouch
Journal: Comput Math Methods Med Date: 2016-11-02 Impact factor: 2.238